480 Chapter | 15 Skeletal Muscle Function Baldwin , K. M. , Winder , W. W. , Terjung , R. L. , and Holloszy , J. O. ( 1973 ). Glycolytic enzymes in different types <strong>of</strong> skeletal muscle: adaptation to exercise . Am. J. Physiol. 225 , 962 – 966 . Barany , M. ( 1967 ). ATPase activity <strong>of</strong> myosin correlated with speed <strong>of</strong> muscle shortening . J. Gen. Physiol. 50 ( suppl 218 ) , 197 – 218 . Barden , J. A. , and Mason , P. ( 1978 ). Muscle crossbridge stroke and activity revealed by optical diffraction . Science 199 , 1212 – 1213 . Bennard , P. , Imbeault , P. , and Doucet , E. ( 2005 ). Maximizing acute fat utilization: effects <strong>of</strong> exercise, food, and individual characteristics . Can. J. Appl. Physiol. 30 , 475 – 499 . Bhalerao , D. P. , Rajpurohit , Y. , Vite , C. H. , and Giger , U. ( 2002 ). Detection <strong>of</strong> a genetic mutation for myotonia congenita among miniature schnauzers and identification <strong>of</strong> a common carrier ancestor . Am. J. Vet. Res. 63 , 1443 – 1447 . Bilstrom , J. A. , Valberg , S. J. , Bernoco , D. , and Mickelson , J. R. ( 1998 ). Genetic test for myophosphorylase deficiency in Charolais cattle . Am. J. Vet. Res. 59 , 267 – 270 . Blackmore , D. J. , and Elton , D. ( 1975 ). Enzyme activity in the serum <strong>of</strong> thoroughbred horses in the United Kingdom . Equine Vet. J. 7 , 34 – 39 . Braund , K. G. , Dillon , A. R. , August , J. R. , and Ganjam , V. K. ( 1981 ). Hypothyroid myopathy in two dogs . Vet. Pathol. 18 , 589 – 598 . Braund , K. G. , Dillon , A. R. , and Mikeal , R. L. ( 1980 a ). Experimental investigation <strong>of</strong> glucocorticoid-induced myopathy in the dog . Exp. Neurol. 68 , 50 – 71 . Braund , K. G. , Dillon , A. R. , Mikeal , R. L. , and August , J. R. ( 1980 b ). Subclinical myopathy associated with hyperadrenocorticism in the dog . Vet. Pathol. 17 , 134 – 148 . Braund , K. G. , H<strong>of</strong>f , E. J. , and Richardson , E. Y. ( 1978 ). Histochemical identification <strong>of</strong> fiber types in canine skeletal muscle . Am. J. Vet. Res. 39 , 561 – 565 . Breitschwerdt, E. B. , Kornegay , J. N. , Wheeler , S. J. , Stevens , J. B. , and Baty , C. J. ( 1992 ). Episodic weakness associated with exertional lactic acidosis and myopathy in Old English sheepdog littermates . J. Am. Vet. Med. Assoc. 201 , 731 – 736 . Brooke , M. H. , and Kaiser , K. K. ( 1970 ). Muscle fiber types: how many and what kind Arch. Neurol. 23 , 369 – 379 . Bryant , S. H. , and Conte-Camerino , D. ( 1991 ). Chloride channel regulation in the skeletal muscle <strong>of</strong> normal and myotonic goats . Pfl ugers Arch. 417 , 605 – 610 . Bulcke , J. A. , and Sherwin , A. L. ( 1969 ). Organ specificity <strong>of</strong> creatine phosphokinase muscle isoenzyme . Immunochemistry 6 , 681 – 687 . Burgener , I. A. , Kovacevic , A. , Mauldin , G. N. , and Lombard , C. W. ( 2006 ). Cardiac troponins as indicators <strong>of</strong> acute myocardial damage in dogs . J. Vet. Intern. Med. 20 , 277 – 283 . Burke , R. E. ( 1975 ). Motor unit properties and selective involvement in movement . Exerc. Sport Sci. Rev. 3 , 31 – 81 . Cannon , S. C. , Hayward , L. J. , Beech , J. , and Brown , R. H ., Jr. ( 1995 ). Sodium channel inactivation is impaired in equine hyperkalemic periodic paralysis . J. Neurophysiol. 73 , 1892 – 1899 . Cardinet , G. H., III, and Holliday , T. A. ( 1979 ). Neuromuscular diseases <strong>of</strong> domestic animals: a summary <strong>of</strong> muscle biopsies from 159 cases . Ann. NY Acad. Sci. 317 , 290 – 313 . Cardinet , G. H. , III, F owler , M. E. , and Tyler , W. S. ( 1963 ). The effects <strong>of</strong> training, exercise, and tying-up on serum transaminase activities in the horse . Am. J. Vet. Res. 24 , 980 – 984 . Cardinet , G. H. , Littrell , J. F. , and Freedland , R. A. (1967 ). Comparative investigations <strong>of</strong> serum creatine phosphokinase and glutamic-oxaloacetic transaminase activities in equine paralytic myoglobinuria . Res. Vet. Sci. 8 , 219 – 226 . Carling , D. ( 2004 ). The AMP-activated protein kinase cascade: a unifying system for energy control . Trends Biochem. Sci. 29 , 18 – 24 . Ceh , L. , Hauge , J. G. , Svenkerud , R. , and Strande , A. ( 1976 ). Glycogenosis type III in the dog . Acta Vet. Scand. 17 , 210 – 222 . Cornelius , C. E. , Bishop , J. , Switzer , J. , and Rhode , E. A. ( 1959 ). Serum and tissue transaminase activities in domestic animals . Cornell Vet. 49 , 116 – 126 . Cornelius , C. E. , Burnham , L. G. , and Hill , H. E. ( 1963 ). Serum transaminase activities <strong>of</strong> thoroughbred horses in training . J. Am. Vet. Med. Assoc. 142 , 639 – 642 . Craig , R. W. , and Padron , R. ( 2004 ). Molecular structure <strong>of</strong> the sarcomere . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini-Armstrong , Eds.) , pp. 129 –166 . McGraw-Hill , New York . Cutmore , C. M. , Snow , D. H. , and Newsholme , E. A. ( 1986 ). Effects <strong>of</strong> training on enzyme activities involved in purine nucleotide metabolism in Thoroughbred horses . Equine Vet. J. 18 , 72 – 73 . Davis , B. M. , McCurrach , M. E. , Taneja , K. L. , Singer , R. H. , and Housman , D. E. ( 1997 ). Expansion <strong>of</strong> a CUG trinucleotide repeat in the 3 untranslated region <strong>of</strong> myotonic dystrophy protein kinase transcripts results in nuclear retention <strong>of</strong> transcripts . Proc. Natl. Acad. Sci. USA 94 , 7388 – 7393 . Dawson , D. M. , Eppenberger , H. M. , and Eppenberger , M. E. ( 1968 ). Multiple molecular forms <strong>of</strong> creatine kinases . Ann. NY Acad. Sci. 151 , 616 – 626 . Dawson , D. M. , and Fine , I. H. ( 1967 ). Creatine kinase in human tissues . Arch. Neurol. 16 , 175 – 180 . Dawson , D. M. , and Romanul , F. C. ( 1964 ). Enzymes in muscles. II. Histochemical and quantitative studies . Arch. Neurol. 11 , 369 – 378 . De La Corte , F. D. , Valberg , S. J. , MacLeay , J. M. , Williamson , S. E. , and Mickelson , J. R. ( 1999 ). Glucose uptake in horses with polysaccharide storage myopathy . Am. J. Vet. Res. 60 , 458 – 462 . Dennis , J. A. , Moran , C. , and Healy , P. J. ( 2000 ). The bovine alphaglucosidase gene: coding region, genomic structure, and mutations that cause bovine generalized glycogenosis . Mamm. Genome 11 , 206 – 212 . Dewey , C. W. , Bailey , C. S. , Shelton , G. D. , Kass , P. H. , and Cardinet , G. H. , III. ( 1997 ). <strong>Clinical</strong> forms <strong>of</strong> acquired myasthenia gravis in dogs: 25 cases (1988–1995) . J. Vet. Intern. Med. 11 , 50 – 57 . Dickinson , P. J. , Sturges , B. K. , Shelton , G. D. , and Lecouteur , R. A. ( 2005 ). Congenital myasthenia gravis in smooth-haired miniature dachshund dogs . J. Vet. Intern. Med. 19 , 920 – 923 . DiMauro , S. , and Bonilla , E. ( 2004 ). Mitochondrial encephalomyopathies . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini- Armstrong , Eds.) , pp. 1623 – 1662 . McGraw-Hill , New York . DiMauro , S. , Tsujino , S. , Shanske , S. , and Rowland , L. P. ( 1995 ). <strong>Biochemistry</strong> and molecular genetics <strong>of</strong> human glycogenoses: an overview . Muscle Nerve 3 , S10 – S17 . Dorling , P. R. , Howell , J. M. , and Gawthorne , J. M. ( 1981 ). Skeletalmuscle alpha-glucosidases in bovine generalized glycogenosis type II . Biochem. J. 198 , 409 – 412 . Dubowitz , V. , and Brooke , M. H. ( 1973 ). “ Muscle Biopsy: A Modern Approach. ” pp. 1–471 . Saunders , Philadelphia . Duncan , I. D. , Griffiths , I. R. , and Nash , A. S. ( 1977 ). Myotonia in canine Cushing’s disease . Vet. Rec. 100 , 30 – 31 . Eccles , J. C. , Eccles , R. M. , and Lundberg , A. ( 1958 ). The action potentials <strong>of</strong> the alpha motoneurones supplying fast and slow muscles . J. Physiol. 142 , 275 – 291 . Eisenberg , E. , Dobkin , L. , and Kielley , W. W. ( 1972 ). Binding <strong>of</strong> actin to heavy meromyosin in the absence <strong>of</strong> adenosine triphosphate . <strong>Biochemistry</strong> 11 , 4657 – 4660 . Engel , A. , and Franzini-Armstrong , C. ( 2004 ). “ Myology: Basic and <strong>Clinical</strong> . ” McGraw-Hill , New York .
References 481 Engel , A. G. ( 2004 ). Neuromuscular junction . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini-Armstrong , Eds.) , pp. 325 – 373 . McGraw-Hill , New York . Engel , A. G. , and Hohfield , R. ( 2004 ). Acquired autoimmune myasthenia gravis . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini-Armstrong , Eds.) , pp. 1755 –1790 . McGraw-Hill , New York . Engel , A. G. , Ohno , K. , and Sine , S. ( 2004 ). Congenital myasthenia gravis . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini- Armstrong , Eds.) , pp. 1801 – 1844 . McGraw-Hill , New York . Eppenberger , H. M. , Eppenberger , M. , Richterich , R. , and Aebi , H. (1964 ). The ontogeny <strong>of</strong> creatine kinase isozymes . Dev. Biol. 10 , 1 – 16 . Essen-Gustavsson , B. , Roneus , N. , and Poso , A. R. ( 1997 ). Metabolic response in skeletal muscle fibres <strong>of</strong> standardbred trotters after racing . Comp. Biochem. Physiol. B Biochem. Mol. Biol. 117 , 431 – 436 . Eto , D. , Yamano , S. , Kasashima , Y. , Sugiura , T. , Nasu , T. , Tokuriki , M. , and Miyata , H. (2003 ). Effect <strong>of</strong> controlled exercise on middle gluteal muscle fibre composition in thoroughbred foals . Equine Vet. J. 35 , 676 –680 . Eto , D. , Yamano , S. , Mukai , K. , Sugiura , T. , Nasu , T. , Tokuriki , M. , and Miyata , H. ( 2004 ). Effect <strong>of</strong> high intensity training on anaerobic capacity <strong>of</strong> middle gluteal muscle in thoroughbred horses . Res. Vet. Sci. 76 , 139 – 144 . Evans , J. , Levesque , D. , and Shelton , G. D. ( 2004 ). Canine inflammatory myopathies: a clinicopathologic review <strong>of</strong> 200 cases . J. Vet. Intern. Med. 18 , 679 – 691 . Fiolet , J. W. , Willebrands , A. F. , Lie , K. I. , and ter Welle , H. F. ( 1977 ). Determination <strong>of</strong> creatine kinase isoenzyme MB (CK-MB): comparison <strong>of</strong> methods and clinical evaluation . Clin. Chim. Acta 80 , 23 – 35 . Firshman , A. M. , Baird , J. D. , and Valberg , S. J. ( 2005 ). Prevalences and clinical signs <strong>of</strong> polysaccharide storage myopathy and shivers in Belgian draft horses . J. Am. Vet. Med. Assoc. 227 , 1958 – 1964 . Franzini-Armstrong , C. , and Horowitz , A. R. ( 2004 ). The cytoskeleton: maintenance <strong>of</strong> muscle fiber integrity . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini-Armstrong , Eds.) , pp. 443 – 454 . McGraw-Hill , New York . Fuchs , S. , Kornowski , R. , Mehran , R. , Satler , L. F. , Pichard , A. D. , Kent , K. M. , Hong , M. K. , Slack , S. , Stone , G. W. , and Leon , M. B. ( 1999 ). Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role <strong>of</strong> early percutaneous revascularization . J. Am. Coll. Cardiol. 34 , 1704 – 1710 . Fujii , J. , Otsu , K. , Zorzato , F. , De , L. S. , Khanna , V. K. , Weiler , J. E. , O’Brien , P. J. , and Maclennan , D. H. ( 1991 ). Identification <strong>of</strong> a mutation in porcine ryanodine receptor associated with malignant hyperthermia . Science 253 , 448 – 451 . Fyfe , J. C. ( 1995 ). Glycogen storage disease in cats . J. Am. Vet. Med. Assoc. 206 , 286 . Fyfe , J. C. , Giger , U. , Van Winkle , T. J. , Haskins , M. E. , Steinberg , S. A. , Wang , P. , and Patterson , D. F. ( 1992 ). Glycogen storage disease type IV: inherited deficiency <strong>of</strong> branching enzyme activity in cats . Pediatr. Res. 32 , 719 – 725 . Giger , U. , Argov , Z. , Schnall , M. , Bank , W. J. , and Chance , B. ( 1988 a ). Metabolic myopathy in canine muscle-type phosph<strong>of</strong>ructokinase deficiency . Muscle Nerve 11 , 1260 – 1265 . Giger , U. , Harvey , J. W. , Yamaguchi , R. A. , McNulty , P. K. , Chiapella , A. , and Beutler , E. ( 1985 ). Inherited phosph<strong>of</strong>ructokinase deficiency in dogs with hyperventilation-induced hemolysis: increased in vitro and in vivo alkaline fragility <strong>of</strong> erythrocytes . Blood 65 , 345 – 351 . Giger , U. , Kelly , A. M. , and Teno , P. S. ( 1988 b ). Biochemical studies <strong>of</strong> canine muscle phosph<strong>of</strong>ructokinase deficiency . Enzyme 40 , 25 – 29 . Giger , U. , Reilly , M. P. , Asakura , T. , Baldwin , C. J. , and Harvey , J. W. ( 1986 ). Autosomal recessive inherited phosph<strong>of</strong>ructokinase deficiency in English springer spaniel dogs . Anim. Genet. 17 , 15 – 23 . Golland , L. C. , Evans , D. L. , McGowan , C. M. , Hodgson , D. R. , and Rose , R. J. ( 2003 ). The effects <strong>of</strong> overtraining on blood volumes in standardbred racehorses . Vet. J. 165 , 228 – 233 . Gollnick , P. D. , Armstrong , R. B. , Saubert , C. W. , Piehl , K. , and Saltin , B. ( 1972 ). Enzyme activity and fiber composition in skeletal muscle <strong>of</strong> untrained and trained men . J. Appl. Physiol. 33 , 312 – 319 . Gorza , L. ( 1990 ). Identification <strong>of</strong> a novel type 2 fiber population in mammalian skeletal muscle by combined use <strong>of</strong> histochemical myosin ATPase and anti-myosin monoclonal antibodies . J. Histochem. Cytochem. 38 , 257 – 265 . Graziotti , G. H. , Rios , C. M. , and Rivero , J. L. ( 2001 ). Evidence for three fast myosin heavy chain is<strong>of</strong>orms in type II skeletal muscle fibers in the adult llama (Lama glama) . J. Histochem. Cytochem. 49 , 1033 – 1044 . Griffin , G. E. , Williams , P. E. , and Goldspink , G. ( 1971 ). Region <strong>of</strong> longitudinal growth in striated muscle fibres . Nat. New Biol. 232 , 28 – 29 . Grobler , L. A. , Collins , M. , Lambert , M. I. , Sinclair-Smith , C. , Derman , W. , St Clair , G. A. , and Noakes , T. D. ( 2004 ). Skeletal muscle pathology in endurance athletes with acquired training intolerance . Br. J. Sports Med. 38 , 697 – 703 . Hamdan , A. , Zafrir , N. , Sagie , A. , and Kornowski , R. ( 2006 ). Modalities to assess myocardial viability in the modern cardiology era . Coron. Artery Dis. 17 , 567 – 576 . Hardie , D. G. (2004 ). AMP-activated protein kinase: a key system mediating metabolic responses to exercise . Med. Sci. Sports Exerc. 36 , 28 – 34 . Harper , P. S. , and Monckton , D. G. (2004 ). Myotonic dystrophy . In “ Myology: Basic and <strong>Clinical</strong> ” ( A. G. Engel and C. Franzini- Armstrong , Eds.) , pp. 1039 – 1076 . McGraw-Hill , New York . Harris , R. C. , Marlin , D. J. , Snow , D. H. , and Harkness , R. A. ( 1991 ). Muscle ATP loss and lactate accumulation at different work intensities in the exercising Thoroughbred horse . Eur. J. Appl. Physiol. Occup. Physiol. 62 , 235 – 244 . Harvey , J. W. , Calderwood Mays , M. B. , Gropp , K. E. , and Denaro , F. J. (1990 ). Polysaccharide storage myopathy in canine phosph<strong>of</strong>ructokinase deficiency (type VII glycogen storage disease) . Vet. Pathol. 27 , 1 – 8 . Harvey , J. W. , and Reddy , G. R. ( 1989 ). Postnatal hematologic development in phosph<strong>of</strong>ructokinase-deficient dogs . Blood 74 , 2556 – 2561 . Havel , R. J. , Ekelund , L. G. , and Holmgren , A. ( 1967 ). Kinetic analysis <strong>of</strong> the oxidation <strong>of</strong> palmitate-1-14C in man during prolonged heavy muscular exercise . J. Lipid Res. 8 , 366 – 373 . Heffron , J. J. , Bomzon , L. , and Pattinson , R. A. ( 1976 ). Observations on plasma creatine phosphokinase activity in dogs . Vet. Rec. 98 , 338 – 340 . Hegreberg , G. A. , and Reed , S. M. ( 1990 ). Skeletal muscle changes associated with equine myotonic dystrophy . Acta Neuropathol. (Berl.) 80 , 426 – 431 . Heine , R. , George , A. L ., Jr. , Pika , U. , Deymeer , F. , Rudel , R. , and Lehmann-Horn , F. ( 1994 ). Pro<strong>of</strong> <strong>of</strong> a non-functional muscle chloride channel in recessive myotonia congenita (Becker) by detection <strong>of</strong> a 4 base pair deletion . Hum. Mol. Genet. 3 , 1123 – 1128 . Henckel , P. ( 1983 ). Training and growth induced changes in the middle gluteal muscle <strong>of</strong> young Standardbred trotters . Equine Vet. J. 15 , 134 – 140 . Hodgson , D. R. ( 1985 ). Muscular adaptations to exercise and training . Vet. Clin. North Am. Equine Pract. 1 , 533 – 548 . H<strong>of</strong>fman , E. P. , Brown , R. H ., Jr. , and Kunkel , L. M. ( 1987 ). Dystrophin: the protein product <strong>of</strong> the Duchenne muscular dystrophy locus . Cell 51 , 919 – 928 . Hoh , J. F. , and Hughes , S. ( 1988 ). Myogenic and neurogenic regulation <strong>of</strong> myosin gene expression in cat jaw-closing muscles regenerating in fast and slow limb muscle beds . J. Muscle Res. Cell Motil. 9 , 59 – 72 .
- Page 1 and 2:
Preface It has been more than a dec
- Page 3 and 4:
viii Contributors Björn P. Meij (5
- Page 5 and 6:
2 Chapter | 1 Concepts of Normality
- Page 7 and 8:
4 Chapter | 1 Concepts of Normality
- Page 9 and 10:
6 Chapter | 1 Concepts of Normality
- Page 11 and 12:
8 Chapter | 1 Concepts of Normality
- Page 13 and 14:
10 Chapter | 1 Concepts of Normalit
- Page 15 and 16:
12 Chapter | 1 Concepts of Normalit
- Page 17 and 18:
14 Chapter | 1 Concepts of Normalit
- Page 19 and 20:
16 Chapter | 1 Concepts of Normalit
- Page 21 and 22:
18 Chapter | 1 Concepts of Normalit
- Page 23 and 24:
20 Chapter | 1 Concepts of Normalit
- Page 25 and 26:
22 Chapter | 1 Concepts of Normalit
- Page 27 and 28:
24 Chapter | 1 Concepts of Normalit
- Page 29 and 30:
Chapter 2 Comparative Medical Genet
- Page 31 and 32:
I. Introduction 29 Green Red Green
- Page 33 and 34:
I. Introduction 31 A1 genetic map d
- Page 35 and 36:
I. Introduction 33 of genomes of va
- Page 38 and 39:
36 Chapter | 2 Comparative Medical
- Page 40 and 41:
38 Chapter | 2 Comparative Medical
- Page 42 and 43:
40 Chapter | 2 Comparative Medical
- Page 44 and 45:
42 Chapter | 2 Comparative Medical
- Page 46 and 47:
44 Chapter | 2 Comparative Medical
- Page 48 and 49:
46 Chapter | 3 Carbohydrate Metabol
- Page 50 and 51:
48 Chapter | 3 Carbohydrate Metabol
- Page 52 and 53:
50 Chapter | 3 Carbohydrate Metabol
- Page 54 and 55:
52 Chapter | 3 Carbohydrate Metabol
- Page 56 and 57:
54 Chapter | 3 Carbohydrate Metabol
- Page 58 and 59:
56 Chapter | 3 Carbohydrate Metabol
- Page 60 and 61:
58 Chapter | 3 Carbohydrate Metabol
- Page 62 and 63:
60 Chapter | 3 Carbohydrate Metabol
- Page 64 and 65:
62 Chapter | 3 Carbohydrate Metabol
- Page 66 and 67:
64 Chapter | 3 Carbohydrate Metabol
- Page 68 and 69:
66 Chapter | 3 Carbohydrate Metabol
- Page 71 and 72:
IX. Disorders of Carbohydrate Metab
- Page 73 and 74:
IX. Disorders of Carbohydrate Metab
- Page 75 and 76:
IX. Disorders of Carbohydrate Metab
- Page 77 and 78:
X. Disorders of Ruminants Associate
- Page 79 and 80:
X. Disorders of Ruminants Associate
- Page 81 and 82:
References 79 Kaneko , J. J. , Luic
- Page 83 and 84:
Chapter 4 Lipids and Ketones Michae
- Page 85 and 86:
II. Long Chain Fatty Acids 83 FIGUR
- Page 87 and 88:
II. Long Chain Fatty Acids 85 Plasm
- Page 89 and 90:
IV. Phospholipids 87 The regulation
- Page 91 and 92:
V. Cholesterol 89 V. CHOLESTEROL A.
- Page 93 and 94:
VI. Lipoproteins 91 TABLE 4-1 Compo
- Page 95 and 96:
VI. Lipoproteins 93 TABLE 4-2 Apoli
- Page 98 and 99:
96 Chapter | 4 Lipids and Ketones B
- Page 100 and 101:
98 Chapter | 4 Lipids and Ketones
- Page 102 and 103:
100 Chapter | 4 Lipids and Ketones
- Page 104 and 105:
102 Chapter | 4 Lipids and Ketones
- Page 106 and 107:
104 Chapter | 4 Lipids and Ketones
- Page 108 and 109:
106 Chapter | 4 Lipids and Ketones
- Page 110 and 111:
108 Chapter | 4 Lipids and Ketones
- Page 112 and 113:
110 Chapter | 4 Lipids and Ketones
- Page 114 and 115:
112 Chapter | 4 Lipids and Ketones
- Page 116 and 117:
114 Chapter | 4 Lipids and Ketones
- Page 118 and 119:
Chapter 5 Proteins, Proteomics, and
- Page 120 and 121:
III. Metabolism of Proteins 119 C .
- Page 122 and 123:
IV. Plasma Proteins 121 NH 4 HCO
- Page 124 and 125:
V. Methodology 123 molecule. The gl
- Page 126 and 127:
V. Methodology 125 has occurred wil
- Page 128 and 129:
V. Methodology 127 Although attempt
- Page 130 and 131:
V. Methodology 129 kD 94 67 43 2 2
- Page 132 and 133:
V. Methodology 131 D . Specific Pro
- Page 134 and 135:
VI. Normal Plasma and Serum Protein
- Page 136 and 137:
VI. Normal Plasma and Serum Protein
- Page 138 and 139:
VI. Normal Plasma and Serum Protein
- Page 140 and 141:
VI. Normal Plasma and Serum Protein
- Page 142 and 143:
VI. Normal Plasma and Serum Protein
- Page 144 and 145:
VII. Interpretation of Serum Protei
- Page 146 and 147:
VII. Interpretation of Serum Protei
- Page 148 and 149:
VII. Interpretation of Serum Protei
- Page 150 and 151:
References 149 Andersson , M. , Ste
- Page 152 and 153:
References 151 response of haptoglo
- Page 154 and 155:
References 153 dogs with metastasiz
- Page 156 and 157:
References 155 Watson , T. D. G. (
- Page 158:
158 Chapter | 6 Clinical Veterinary
- Page 163 and 164:
V. Methods for Evaluation of the Im
- Page 165 and 166:
V. Methods for Evaluation of the Im
- Page 167 and 168:
V. Methods for Evaluation of the Im
- Page 169:
VI. Laboratory Diagnosis of Disease
- Page 173 and 174:
Chapter 7 The Erythrocyte: Physiolo
- Page 175 and 176:
II. Hematopoiesis 175 progenitor ce
- Page 177 and 178:
III. Developing Erythroid Cells 177
- Page 179 and 180:
III. Developing Erythroid Cells 179
- Page 181 and 182:
III. Developing Erythroid Cells 181
- Page 183 and 184:
III. Developing Erythroid Cells 183
- Page 185 and 186:
IV. Mature RBC 185 immune-mediated
- Page 187 and 188:
IV. Mature RBC 187 TABLE 7-3 Erythr
- Page 189 and 190:
IV. Mature RBC 189 TABLE 7.5 Erythr
- Page 191 and 192:
IV. Mature RBC 191 Echinocyte forma
- Page 193 and 194:
IV. Mature RBC 193 Pig RBC isoantig
- Page 195 and 196:
IV. Mature RBC 195 occurs in chicke
- Page 197 and 198:
IV. Mature RBC 197 inorganic phosph
- Page 199 and 200:
IV. Mature RBC 199 (a) FIGURE 7-6 T
- Page 201 and 202:
IV. Mature RBC 201 RBC 2,3DPG incre
- Page 203 and 204:
IV. Mature RBC 203 mechanisms would
- Page 205 and 206:
IV. Mature RBC 205 released during
- Page 207 and 208:
IV. Mature RBC 207 reduced by ascor
- Page 209 and 210:
V. Determinants of RBC Survival 209
- Page 211 and 212:
V. Determinants of RBC Survival 211
- Page 213 and 214:
VI. Inherited Disorders of RBCs 213
- Page 215 and 216:
VI. Inherited Disorders of RBCs 215
- Page 217 and 218:
VI. Inherited Disorders of RBCs 217
- Page 219 and 220:
described in people. They include a
- Page 221 and 222:
References 221 Boas , F. E. , Forma
- Page 223 and 224:
References 223 Della Rovere , F. ,
- Page 225 and 226:
References 225 Gedde , M. M. , Davi
- Page 227 and 228:
References 227 phosphofructokinase-
- Page 229 and 230:
References 229 Knight , A. P. , Las
- Page 231 and 232:
References 231 Martinovich , D. , a
- Page 233 and 234:
References 233 Pearson , W. , Boerm
- Page 235 and 236:
References 235 Shadduck , R. K. ( 1
- Page 237 and 238:
References 237 Tennant , B. , Dill
- Page 239 and 240:
References 239 Williams , D. M. , L
- Page 241 and 242:
Chapter 8 Porphyrins and the Porphy
- Page 243 and 244:
II. Porphyrins 243 two vinyl groups
- Page 245 and 246:
II. Porphyrins 245 TABLE 8-2 Nomenc
- Page 247 and 248:
IV. Porphyrias 247 6. Uroporphyrins
- Page 249 and 250:
IV. Porphyrias 249 i . Urine It is
- Page 251 and 252:
IV. Porphyrias 251 to localize the
- Page 253 and 254:
IV. Porphyrias 253 FIGURE 8-6 Metab
- Page 255 and 256:
IV. Porphyrias 255 estrogens. The d
- Page 257 and 258:
References 257 and hexachlorobenzen
- Page 259 and 260:
Chapter 9 Iron Metabolism and Its D
- Page 261 and 262:
II. Iron Distribution 261 plasma of
- Page 263 and 264:
IV. Plasma Iron Transport 263 pathw
- Page 265 and 266:
VI. Iron Metabolism in Cells 265 of
- Page 267 and 268:
VI. Iron Metabolism in Cells 267 in
- Page 269 and 270:
VII. Tests for Evaluating Iron Meta
- Page 271 and 272:
VII. Tests for Evaluating Iron Meta
- Page 273 and 274:
VIII. Disorders of Iron Metabolism
- Page 275 and 276:
VIII. Disorders of Iron Metabolism
- Page 277 and 278:
VIII. Disorders of Iron Metabolism
- Page 279 and 280:
References 279 ( Norrdin et al ., 2
- Page 281 and 282:
References 281 Fresco , R. ( 1981 )
- Page 283 and 284:
References 283 Moore , C. V. , Duba
- Page 285 and 286:
References 285 Weiden , P. L. , Hac
- Page 287 and 288:
288 Chapter | 10 Hemostasis TABLE 1
- Page 289 and 290:
290 Chapter | 10 Hemostasis TABLE 1
- Page 291 and 292:
292 Chapter | 10 Hemostasis The pro
- Page 293 and 294:
294 Chapter | 10 Hemostasis exhibit
- Page 295 and 296:
296 Chapter | 10 Hemostasis TABLE 1
- Page 297 and 298:
298 Chapter | 10 Hemostasis that is
- Page 299 and 300:
300 Chapter | 10 Hemostasis TABLE 1
- Page 301 and 302:
302 Chapter | 10 Hemostasis However
- Page 303 and 304:
304 Chapter | 10 Hemostasis 2. Comp
- Page 305 and 306:
306 Chapter | 10 Hemostasis is a re
- Page 307 and 308:
308 Chapter | 10 Hemostasis 2. Asse
- Page 309 and 310:
310 Chapter | 10 Hemostasis necessi
- Page 311 and 312:
312 Chapter | 10 Hemostasis disease
- Page 313 and 314:
314 Chapter | 10 Hemostasis concent
- Page 315 and 316:
316 Chapter | 10 Hemostasis the rol
- Page 317 and 318:
318 Chapter | 10 Hemostasis proport
- Page 319 and 320:
320 Chapter | 10 Hemostasis a consi
- Page 321 and 322:
322 Chapter | 10 Hemostasis Bakhtia
- Page 323 and 324:
324 Chapter | 10 Hemostasis Dowd ,
- Page 325 and 326:
326 Chapter | 10 Hemostasis Kier ,
- Page 327 and 328:
328 Chapter | 10 Hemostasis Nielsen
- Page 329 and 330:
330 Chapter | 10 Hemostasis Tablin
- Page 331 and 332:
332 Chapter | 11 Neutrophil Functio
- Page 333 and 334:
334 Chapter | 11 Neutrophil Functio
- Page 335 and 336:
336 Chapter | 11 Neutrophil Functio
- Page 337 and 338:
338 Chapter | 11 Neutrophil Functio
- Page 339 and 340:
340 Chapter | 11 Neutrophil Functio
- Page 341 and 342:
342 Chapter | 11 Neutrophil Functio
- Page 343 and 344:
344 Chapter | 11 Neutrophil Functio
- Page 345 and 346:
346 Chapter | 11 Neutrophil Functio
- Page 347 and 348:
348 Chapter | 11 Neutrophil Functio
- Page 349 and 350:
350 Chapter | 11 Neutrophil Functio
- Page 351 and 352:
352 Chapter | 12 Diagnostic Enzymol
- Page 353 and 354:
354 Chapter | 12 Diagnostic Enzymol
- Page 355 and 356:
356 Chapter | 12 Diagnostic Enzymol
- Page 357 and 358:
358 Chapter | 12 Diagnostic Enzymol
- Page 359 and 360:
360 Chapter | 12 Diagnostic Enzymol
- Page 361 and 362:
362 Chapter | 12 Diagnostic Enzymol
- Page 363 and 364:
364 Chapter | 12 Diagnostic Enzymol
- Page 365 and 366:
366 Chapter | 12 Diagnostic Enzymol
- Page 367 and 368:
368 Chapter | 12 Diagnostic Enzymol
- Page 369 and 370:
370 Chapter | 12 Diagnostic Enzymol
- Page 371 and 372:
372 Chapter | 12 Diagnostic Enzymol
- Page 373 and 374:
374 Chapter | 12 Diagnostic Enzymol
- Page 375 and 376:
376 Chapter | 12 Diagnostic Enzymol
- Page 377 and 378:
378 Chapter | 12 Diagnostic Enzymol
- Page 379 and 380:
380 Chapter | 13 Hepatic Function L
- Page 381 and 382:
382 Chapter | 13 Hepatic Function e
- Page 383 and 384:
384 Chapter | 13 Hepatic Function p
- Page 385 and 386:
386 Chapter | 13 Hepatic Function m
- Page 387 and 388:
388 Chapter | 13 Hepatic Function s
- Page 389 and 390:
390 Chapter | 13 Hepatic Function f
- Page 391 and 392:
392 Chapter | 13 Hepatic Function T
- Page 393 and 394:
394 Chapter | 13 Hepatic Function 2
- Page 395 and 396:
396 Chapter | 13 Hepatic Function u
- Page 397 and 398:
398 Chapter | 13 Hepatic Function 2
- Page 399 and 400:
400 Chapter | 13 Hepatic Function c
- Page 401 and 402:
402 Chapter | 13 Hepatic Function F
- Page 403 and 404:
404 Chapter | 13 Hepatic Function A
- Page 405 and 406:
406 Chapter | 13 Hepatic Function E
- Page 407 and 408:
408 Chapter | 13 Hepatic Function K
- Page 409 and 410:
410 Chapter | 13 Hepatic Function R
- Page 411 and 412:
412 Chapter | 13 Hepatic Function W
- Page 413 and 414:
414 Chapter | 14 Gastrointestinal F
- Page 415 and 416:
416 Chapter | 14 Gastrointestinal F
- Page 417 and 418:
418 Chapter | 14 Gastrointestinal F
- Page 419 and 420:
420 Chapter | 14 Gastrointestinal F
- Page 421 and 422:
422 Chapter | 14 Gastrointestinal F
- Page 423 and 424:
424 Chapter | 14 Gastrointestinal F
- Page 425 and 426:
426 Chapter | 14 Gastrointestinal F
- Page 427 and 428: 428 Chapter | 14 Gastrointestinal F
- Page 429 and 430: 430 Chapter | 14 Gastrointestinal F
- Page 431 and 432: 432 Chapter | 14 Gastrointestinal F
- Page 433 and 434: 434 Chapter | 14 Gastrointestinal F
- Page 435 and 436: 436 Chapter | 14 Gastrointestinal F
- Page 437 and 438: 438 Chapter | 14 Gastrointestinal F
- Page 439 and 440: 440 Chapter | 14 Gastrointestinal F
- Page 441 and 442: 442 Chapter | 14 Gastrointestinal F
- Page 443 and 444: 444 Chapter | 14 Gastrointestinal F
- Page 445 and 446: 446 Chapter | 14 Gastrointestinal F
- Page 447 and 448: 448 Chapter | 14 Gastrointestinal F
- Page 449 and 450: 450 Chapter | 14 Gastrointestinal F
- Page 451 and 452: 452 Chapter | 14 Gastrointestinal F
- Page 453 and 454: 454 Chapter | 14 Gastrointestinal F
- Page 455 and 456: 456 Chapter | 14 Gastrointestinal F
- Page 457 and 458: Chapter 15 Skeletal Muscle Function
- Page 459 and 460: II. Specialization of the Sarcolemm
- Page 461 and 462: II. Specialization of the Sarcolemm
- Page 463 and 464: III. Heterogeneity of Skeletal Musc
- Page 465 and 466: III. Heterogeneity of Skeletal Musc
- Page 467 and 468: V. Exercise and Adaptations to Trai
- Page 469 and 470: VI. Diagnostic Laboratory Methods f
- Page 471 and 472: VI. Diagnostic Laboratory Methods f
- Page 473 and 474: IX. Selected Neuromuscular Disorder
- Page 475 and 476: IX. Selected Neuromuscular Disorder
- Page 477: References 479 and, recently, there
- Page 481 and 482: References 483 Paciello , O. , Maio
- Page 483 and 484: Chapter 16 Kidney Function and Dama
- Page 485 and 486: II. Kidney Morphology and Function
- Page 487 and 488: II. Kidney Morphology and Function
- Page 489 and 490: III. Tests of Kidney Function 491 (
- Page 491 and 492: III. Tests of Kidney Function 493 T
- Page 493 and 494: III. Tests of Kidney Function 495 B
- Page 495 and 496: 6 5 4 3 2 1 0 Dog Cat Equine Cattle
- Page 497 and 498: III. Tests of Kidney Function 499 d
- Page 499 and 500: IV. Tests of Kidney Damage 501 1000
- Page 501 and 502: IV. Tests of Kidney Damage 503 and
- Page 503 and 504: IV. Tests of Kidney Damage 505 Enzy
- Page 505 and 506: V. Biochemical Changes in Kidney Di
- Page 507 and 508: V. Biochemical Changes in Kidney Di
- Page 509 and 510: References 511 were reported to occ
- Page 511 and 512: References 513 Bovee , K. C. ( 1969
- Page 513 and 514: References 515 Deguchi , E. , and A
- Page 515 and 516: References 517 Fleming , S. A. , Hu
- Page 517 and 518: References 519 Harvey , D. G. ( 197
- Page 519 and 520: References 521 Kühl , S. , Mischke
- Page 521 and 522: References 523 creatinine measureme
- Page 523 and 524: References 525 Reusch , C. , Vochez
- Page 525 and 526: References 527 Terry , R. , Hawkins
- Page 527 and 528: Chapter 17 Fluid, Electrolyte, and
- Page 530 and 531:
532 Chapter | 17 Fluid, Electrolyte
- Page 534 and 535:
536 Chapter | 17 Fluid, Electrolyte
- Page 536 and 537:
538 Chapter | 17 Fluid, Electrolyte
- Page 538 and 539:
540 Chapter | 17 Fluid, Electrolyte
- Page 540 and 541:
542 Chapter | 17 Fluid, Electrolyte
- Page 542 and 543:
544 Chapter | 17 Fluid, Electrolyte
- Page 544 and 545:
546 Chapter | 17 Fluid, Electrolyte
- Page 546 and 547:
548 Chapter | 17 Fluid, Electrolyte
- Page 548 and 549:
550 Chapter | 17 Fluid, Electrolyte
- Page 551 and 552:
VIII. Clinicopathological Indicator
- Page 553 and 554:
References 555 plasma water, electr
- Page 555 and 556:
References 557 Krzywanek , H. ( 197
- Page 557 and 558:
References 559 Strombeck , D. R. (1
- Page 559 and 560:
562 Chapter | 18 Pituitary Function
- Page 561 and 562:
564 Chapter | 18 Pituitary Function
- Page 563 and 564:
566 Chapter | 18 Pituitary Function
- Page 565 and 566:
568 Chapter | 18 Pituitary Function
- Page 567 and 568:
570 Chapter | 18 Pituitary Function
- Page 569 and 570:
572 Chapter | 18 Pituitary Function
- Page 571 and 572:
574 Chapter | 18 Pituitary Function
- Page 573 and 574:
576 Chapter | 18 Pituitary Function
- Page 575 and 576:
578 Chapter | 18 Pituitary Function
- Page 577 and 578:
580 Chapter | 18 Pituitary Function
- Page 579 and 580:
582 Chapter | 18 Pituitary Function
- Page 581 and 582:
584 Chapter | 18 Pituitary Function
- Page 583 and 584:
586 Chapter | 18 Pituitary Function
- Page 585 and 586:
588 Chapter | 18 Pituitary Function
- Page 587 and 588:
590 Chapter | 18 Pituitary Function
- Page 589 and 590:
592 Chapter | 18 Pituitary Function
- Page 591 and 592:
594 Chapter | 18 Pituitary Function
- Page 593 and 594:
596 Chapter | 18 Pituitary Function
- Page 595 and 596:
598 Chapter | 18 Pituitary Function
- Page 597 and 598:
600 Chapter | 18 Pituitary Function
- Page 599 and 600:
602 Chapter | 18 Pituitary Function
- Page 601 and 602:
604 Chapter | 18 Pituitary Function
- Page 603 and 604:
606 Chapter | 19 Adrenocortical Fun
- Page 605 and 606:
608 Chapter | 19 Adrenocortical Fun
- Page 607 and 608:
610 Chapter | 19 Adrenocortical Fun
- Page 609 and 610:
612 Chapter | 19 Adrenocortical Fun
- Page 611 and 612:
614 Chapter | 19 Adrenocortical Fun
- Page 613 and 614:
616 Chapter | 19 Adrenocortical Fun
- Page 615 and 616:
618 Chapter | 19 Adrenocortical Fun
- Page 617 and 618:
620 Chapter | 19 Adrenocortical Fun
- Page 619 and 620:
622 Chapter | 19 Adrenocortical Fun
- Page 621 and 622:
624 Chapter | 20 Thyroid Function a
- Page 623 and 624:
626 Chapter | 20 Thyroid Function t
- Page 625 and 626:
628 Chapter | 20 Thyroid Function A
- Page 627 and 628:
630 Chapter | 20 Thyroid Function S
- Page 629 and 630:
632 Chapter | 20 Thyroid Function a
- Page 631 and 632:
634 Chapter | 20 Thyroid Function O
- Page 633 and 634:
636 Chapter | 21 Clinical Reproduct
- Page 635 and 636:
638 Chapter | 21 Clinical Reproduct
- Page 637 and 638:
640 Chapter | 21 Clinical Reproduct
- Page 639 and 640:
642 Chapter | 21 Clinical Reproduct
- Page 641 and 642:
644 Chapter | 21 Clinical Reproduct
- Page 643 and 644:
646 Chapter | 21 Clinical Reproduct
- Page 645 and 646:
648 Chapter | 21 Clinical Reproduct
- Page 647 and 648:
650 Chapter | 21 Clinical Reproduct
- Page 649 and 650:
652 Chapter | 21 Clinical Reproduct
- Page 651 and 652:
654 Chapter | 21 Clinical Reproduct
- Page 653 and 654:
656 Chapter | 21 Clinical Reproduct
- Page 655 and 656:
658 Chapter | 21 Clinical Reproduct
- Page 657 and 658:
660 Chapter | 21 Clinical Reproduct
- Page 659 and 660:
662 Chapter | 21 Clinical Reproduct
- Page 661 and 662:
664 Chapter | 22 Trace Minerals the
- Page 663 and 664:
666 Chapter | 22 Trace Minerals the
- Page 665 and 666:
668 Chapter | 22 Trace Minerals P i
- Page 667 and 668:
670 Chapter | 22 Trace Minerals be
- Page 669 and 670:
Copper Cuproreductase Cytochromes C
- Page 671 and 672:
674 Chapter | 22 Trace Minerals 2 .
- Page 673 and 674:
676 Chapter | 22 Trace Minerals Cor
- Page 675 and 676:
678 Chapter | 22 Trace Minerals inf
- Page 677 and 678:
680 Chapter | 22 Trace Minerals tis
- Page 679 and 680:
682 Chapter | 22 Trace Minerals VI
- Page 681 and 682:
684 Chapter | 22 Trace Minerals red
- Page 683 and 684:
686 Chapter | 22 Trace Minerals of
- Page 685 and 686:
688 Chapter | 22 Trace Minerals Per
- Page 687 and 688:
690 Chapter | 22 Trace Minerals In
- Page 689 and 690:
692 Chapter | 22 Trace Minerals Liu
- Page 691 and 692:
Chapter 23 Vitamins Robert B. Rucke
- Page 693 and 694:
III. Fat-Soluble Vitamins 697 TABLE
- Page 695 and 696:
III. Fat-Soluble Vitamins 699 Carot
- Page 697 and 698:
III. Fat-Soluble Vitamins 701 Major
- Page 699 and 700:
III. Fat-Soluble Vitamins 703 doses
- Page 701 and 702:
III. Fat-Soluble Vitamins 705 Diet
- Page 703 and 704:
III. Fat-Soluble Vitamins 707 conta
- Page 705 and 706:
III. Fat-Soluble Vitamins 709 immun
- Page 707 and 708:
IV. Water-Soluble Vitamins 711 are
- Page 709 and 710:
IV. Water-Soluble Vitamins 713 abil
- Page 711 and 712:
IV. Water-Soluble Vitamins 715 5’
- Page 713 and 714:
IV. Water-Soluble Vitamins 717 H 2
- Page 715 and 716:
IV. Water-Soluble Vitamins 719 Enzy
- Page 718 and 719:
722 Chapter | 23 Vitamins When biot
- Page 720 and 721:
724 Chapter | 23 Vitamins Cyanocoba
- Page 722 and 723:
726 Chapter | 23 Vitamins V . VITAM
- Page 724 and 725:
728 Chapter | 23 Vitamins nature, r
- Page 726 and 727:
730 Chapter | 23 Vitamins Stites ,
- Page 728 and 729:
732 Chapter | 24 Lysosomal Storage
- Page 730 and 731:
734 Chapter | 24 Lysosomal Storage
- Page 732 and 733:
736 Chapter | 24 Lysosomal Storage
- Page 734 and 735:
738 Chapter | 24 Lysosomal Storage
- Page 736 and 737:
740 Chapter | 24 Lysosomal Storage
- Page 738 and 739:
742 Chapter | 24 Lysosomal Storage
- Page 740 and 741:
744 Chapter | 24 Lysosomal Storage
- Page 742 and 743:
746 Chapter | 24 Lysosomal Storage
- Page 744 and 745:
748 Chapter | 24 Lysosomal Storage
- Page 746 and 747:
Chapter 25 Tumor Markers Michael D.
- Page 748 and 749:
II. Serum Tumor Markers 753 also be
- Page 750 and 751:
III. Flow Cytometry 755 cancer of t
- Page 752 and 753:
V. Immunohistochemistry/Immunocytoc
- Page 754 and 755:
V. Immunohistochemistry/Immunocytoc
- Page 756 and 757:
References 761 analysis will facili
- Page 758 and 759:
References 763 Fernandez , N. J. ,
- Page 760 and 761:
References 765 Meinecke , B. , and
- Page 762 and 763:
References 767 Walter , J. ( 2000 )
- Page 764 and 765:
770 Chapter | 26 Cerebrospinal Flui
- Page 766 and 767:
772 Chapter | 26 Cerebrospinal Flui
- Page 768 and 769:
774 Chapter | 26 Cerebrospinal Flui
- Page 770 and 771:
776 Chapter | 26 Cerebrospinal Flui
- Page 772 and 773:
778 Chapter | 26 Cerebrospinal Flui
- Page 774 and 775:
TABLE 26-7 Continued Constituent Ro
- Page 776 and 777:
782 Chapter | 26 Cerebrospinal Flui
- Page 778 and 779:
784 Chapter | 26 Cerebrospinal Flui
- Page 780 and 781:
786 Chapter | 26 Cerebrospinal Flui
- Page 782 and 783:
788 Chapter | 26 Cerebrospinal Flui
- Page 784 and 785:
790 Chapter | 26 Cerebrospinal Flui
- Page 786 and 787:
792 Chapter | 26 Cerebrospinal Flui
- Page 788 and 789:
794 Chapter | 26 Cerebrospinal Flui
- Page 790 and 791:
796 Chapter | 26 Cerebrospinal Flui
- Page 792 and 793:
798 Chapter | 26 Cerebrospinal Flui
- Page 794 and 795:
800 Chapter | 26 Cerebrospinal Flui
- Page 796 and 797:
802 Chapter | 26 Cerebrospinal Flui
- Page 798 and 799:
804 Chapter | 26 Cerebrospinal Flui
- Page 800 and 801:
806 Chapter | 26 Cerebrospinal Flui
- Page 802 and 803:
808 Chapter | 26 Cerebrospinal Flui
- Page 804 and 805:
810 Chapter | 26 Cerebrospinal Flui
- Page 806 and 807:
812 Chapter | 26 Cerebrospinal Flui
- Page 808 and 809:
814 Chapter | 26 Cerebrospinal Flui
- Page 810 and 811:
816 Chapter | 26 Cerebrospinal Flui
- Page 812 and 813:
818 Chapter | 26 Cerebrospinal Flui
- Page 814 and 815:
Chapter 27 Clinical Biochemistry in
- Page 816 and 817:
II. Hepatotoxicity 823 Therefore, A
- Page 818 and 819:
III. Nephrotoxicity 825 suggested a
- Page 820 and 821:
IV. Toxins Affecting Skeletal and C
- Page 822 and 823:
VII. Toxins Affecting Erythrocytes
- Page 824 and 825:
VIII. Toxins Affecting Hemoglobin a
- Page 826 and 827:
IX. Toxins Affecting the Nervous Sy
- Page 828 and 829:
References 835 Plants classified as
- Page 830 and 831:
References 837 Solaiman , S. G. , M
- Page 832 and 833:
840 Chapter | 28 Avian Clinical Bio
- Page 834 and 835:
842 Chapter | 28 Avian Clinical Bio
- Page 836 and 837:
844 Chapter | 28 Avian Clinical Bio
- Page 838 and 839:
846 Chapter | 28 Avian Clinical Bio
- Page 840 and 841:
848 Chapter | 28 Avian Clinical Bio
- Page 842 and 843:
850 Chapter | 28 Avian Clinical Bio
- Page 844 and 845:
Budgerigar ALAT (IU/g tissue) Budge
- Page 846 and 847:
854 Chapter | 28 Avian Clinical Bio
- Page 848 and 849:
856 Chapter | 28 Avian Clinical Bio
- Page 850 and 851:
858 Chapter | 28 Avian Clinical Bio
- Page 852 and 853:
860 Chapter | 28 Avian Clinical Bio
- Page 854 and 855:
862 Chapter | 28 Avian Clinical Bio
- Page 856 and 857:
864 Chapter | 28 Avian Clinical Bio
- Page 858 and 859:
866 Chapter | 28 Avian Clinical Bio
- Page 860 and 861:
868 Chapter | 28 Avian Clinical Bio
- Page 862 and 863:
870 Chapter | 28 Avian Clinical Bio
- Page 864 and 865:
872 Chapter | 28 Avian Clinical Bio
- Page 866 and 867:
874 Appendix | I SI Units TABLE E S
- Page 868 and 869:
Appendix II Conversion Factors of S
- Page 870 and 871:
Appendix IV Stability of Serum Enzy
- Page 872 and 873:
Appendix VI Nomogram for Computing
- Page 874 and 875:
t0100 Appendix VIII Blood Analyte R
- Page 876 and 877:
884 Appendix | VIII Blood Analyte R
- Page 878 and 879:
886 Appendix | VIII Blood Analyte R
- Page 880 and 881:
888 Appendix | VIII Blood Analyte R
- Page 882 and 883:
890 Appendix | IX Blood Analyte Ref
- Page 884 and 885:
892 Appendix | IX Blood Analyte Ref
- Page 886 and 887:
894 Appendix | IX Blood Analyte Ref
- Page 888 and 889:
Appendix X Blood Analyte Reference
- Page 890 and 891:
Appendix XI Blood Analyte Reference
- Page 892 and 893:
Appendix XII Urine Analyte Referenc
- Page 894 and 895:
902 Appendix | XIII Cerebrospinal F
- Page 896:
904 Appendix | XIV Cerebrospinal Fl